Remove Blood Pressure Remove Hypertension Remove Reimbursement
article thumbnail

CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

DAIC

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. Food and Drug Administration (FDA) approved Recor’s Paradise Ultrasound Renal Denervation system for the treatment of hypertension on Nov.

CMS 40
article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies.

article thumbnail

Recor Medical’s Paradise Renal Denervation System Lands FDA Approval

CardiacWire

That could be huge for these millions of patients, and for Recor Medical, which is now the clear frontrunner in what might prove to be a multi-billion dollar market.